Diabetes

Editor's Choice

  • Telmisartan/hydrochlorothiazide
    Background: The Study of Micardis (telmisartan) in Overweight/Obese patients with Type 2 diabetes and Hypertension (SMOOTH) compared hydrochlorothiazide (HCTZ) plus telmisartan or valsartan...
  • Healthy Hearts
    A range of risk factors for coronary heart disease (CHD) have been identified and the probability of adverse cardiovascular events over the subsequent 10 years can be predicted using tools such as...
more

Upcoming events

Cardiovascular Disease Prevention 2009: Seventh Annual Comprehensive Symposium

5th - 7th February 2009

We are pleased to announce the Cardiovascular Disease Prevention 2009 A key strategy for addressing cardiovascular heart...

World Congress of Internal Medicine

20th - 25th March 2010

WCIM 2010 and Physicians Week, will offer a stimulating educational program with many networking opportunities with your peers and a chance to keep...

more

Medical Guidelines

  • Surgery
    Perioperative cardiovascular evaluation
    To provide clinical risk profile that the patient, primary physician, nonphysician caregivers, anesthesiologist and surgeon can use in making treatment decisions that influence short- and long-term...
  • Pills
    ACE inhibitors in CV disease
    To review the rationale and clinical evidence for the use of angiotensin converting enzyme inhibitors (ACE-I) in patients with cardiovascular disease. INTENDED USERS: Physicians....
more

Latest News

12th November 2008 - Drug Eluting Stents Beat Bare Metal Stents In Diabetics
8th November 2008 - Clinical Guideline On Prevention Of Cardiovascular Disease And Diabetes In Patients At Highest Risk Released
31st October 2008 - Metformin For Diabetes Associated With Lower Death Risk From Cardiovascular Events
6th October 2008 - Newly Identified Cells Make Fat
more